Advertisement

Topics

Apple Tree leads $50mm Series B round for Syntimmune

15:40 EDT 21 Jun 2017 | Elsevier Business Intelligence

Syntimmune Inc. (developing immune disease therapies targeting the neonatal Fc receptor (FcRn)) raised $50mm through its Seri...

Original Article: Apple Tree leads $50mm Series B round for Syntimmune

NEXT ARTICLE

More From BioPortfolio on "Apple Tree leads $50mm Series B round for Syntimmune"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...